- $1.13bn
- $737.13m
- $45.95m
Annual income statement for Septerna, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0.151 | 1.07 | 46 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 28 | -1.92 | 81.9 | 114 |
| Operating Profit | -28 | 2.08 | -80.8 | -68.3 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -27.7 | 4.87 | -72.3 | -48.9 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -27.7 | 4.18 | -71.8 | -48.9 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -27.7 | 4.18 | -71.8 | -48.9 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -27.7 | 0.567 | -71.8 | -48.9 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.659 | -0.724 | -7.26 | -1.29 |
| Dividends per Share |